Related Experiment Videos
Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex
Wanping Xu1, Xitong Yuan, Zhexin Xiang
1Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Rockville, Maryland 20850, USA.
Nature Structural & Molecular Biology
|January 12, 2005
Summary
Researchers found a specific loop in ErbB2 protein that controls its binding to Hsp90. Altering this loop affects Hsp90 interaction and resistance to cancer drug geldanamycin (GA).
Area of Science:
- Molecular biology
- Cell signaling
- Cancer research
Background:
- The molecular chaperone Hsp90 is crucial for cell signaling protein function.
- Targeting Hsp90 with geldanamycin (GA) is a potential cancer therapy strategy.
- Determinants of Hsp90 client protein interactions are not well understood.
Purpose of the Study:
- To identify the specific region of ErbB2 responsible for Hsp90 binding.
- To understand how ErbB2's surface properties influence Hsp90 interaction.
- To investigate the role of this region in geldanamycin (GA) resistance.
Main Methods:
- Protein analysis of the ErbB2 kinase domain.
- Site-directed mutagenesis to alter specific amino acid sequences.
- Assessment of Hsp90 binding and GA sensitivity.
Main Results:
- A loop in the N lobe of the ErbB2 kinase domain was identified as the Hsp90 binding determinant.
- The loop's amino acid sequence dictates surface electrostatic and hydrophobic properties, governing Hsp90 interaction.
- A point mutation in this loop disrupted Hsp90 binding and conferred GA resistance.
- Immature ErbB2 mutants remained GA-sensitive, suggesting distinct binding mechanisms for nascent and mature client kinases.
Conclusions:
- The identified loop in ErbB2 is critical for Hsp90 chaperone association.
- Surface properties modulated by this loop are key for Hsp90 client interactions.
- Distinct motifs may mediate Hsp90 binding for immature versus mature ErbB2 client kinases, impacting therapeutic strategies.